IDEX (IEX) Stock Fundamentals, Analysis & Risk Signals

Health score, price, valuation, risk signals, and key metrics at a glance.

IDEX

NYSE•Industrials•Specialty Industrial Machinery

$236.52+2.68(0.01%)Pre-market

Market Cap

$17.43B

P/E

32.5x

P/S

4.8x

P/B

4.3x

IDEX Corporation, together with its subsidiaries, provides applied solutions in the United States, North America, Europe, Asia, and internationally. It operates through three segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP). The HST segment designs, produces, and distributes a range of precision fluidics, positive displacement pumps, powder and liquid processing technologies, drying systems, micro-precision components, pneumatic components and sealing solutions, high performance molded and extruded sealing components, and custom mechanical and shaft seals. This segment also offers engineered hygienic mixers and valves, biocompatible medical devices and implantable products, air compressors and blowers, optical components and coatings, ultra-precision diamond tools, and laboratory and commercial equipment, as well as precision photonic solutions, technical ceramics, hermetic sealing products, porous material structures, and flow control solutions. The FMT segment designs, produces, and distributes positive displacement pumps, valves, small volume provers, flow meters, injectors, other fluid-handling pump modules, and systems; and provides flow monitoring and other services. The FSDP segment designs, produces, and distributes firefighting pumps, valves and controls, and rescue tools; lifting bags and other components and systems; engineered stainless steel banding and clamping devices; and precision equipment for dispensing, metering, and mixing colorants and paints. The company was incorporated in 1987 and is headquartered in Northbrook, Illinois.

How this company scores

ExcellentMetricSide Score: 81/100

Strongest: Profitability (23/25); weakest: Balance Sheet & Red Flags (16/25).

Profitability23/25

Growth19/25

Balance Sheet & Red Flags16/25

Cash & Earnings Quality23/25

Strengths

Strong marginsLow leverageCash-backed earningsConsistent free cash flow

No red flags in the last 8 quarters.

Valuation vs. 5-year range

Today's multiple positioned against its own trailing range — a visual premium/discount check.

P/E · 32.5x5y range 25.5x – 39.9x

Currently near its 20-quarter median.

P/S · 4.8x5y range 3.6x – 6.5x

Currently near its 20-quarter median.

P/B · 4.3x5y range 3.0x – 6.4x

Price & Volume

Market Cap $17.43B

Metrics at a Glance

as of September 2026

Revenue & Profit

Revenue, EBITDA, operating income, net income, EPS, and shares

TTM Revenue: $3.66B
Q. Revenue: $951.70M
TTM EBITDA: $977.90M
TTM Op. Income: $763.90M
Q. Op. Income: $208.00M
TTM Net Income: $535.80M
Q. Net Income: $144.10M
EPS: $1.95
Shares Out.: $73.70M

$3.66B in TTM revenue grew 6.9% YoY, reaching $951.70M last quarter. TTM EBITDA of $977.90M and TTM operating income of $763.90M show growth is flowing through to the bottom line. TTM net income of $535.80M means revenue is converting into profit. Across the last 8 quarters, TTM revenue has risen for 7 consecutive quarters — an improving trend.

Margins

Gross, EBITDA, operating, and net margin trends

Gross Margin: 45.1%
EBITDA Margin: 27.5%
Op. Margin: 21.9%
Net Margin: 15.1%

Op. margin of 21.9% is up 0.7% YoY — cost efficiency is improving. Net margin at 15.1% and gross margin of 45.1% show how much of each revenue dollar survives to profit. Across the last 8 quarters, operating margin has risen for 2 consecutive quarters — an improving trend.

Price Ratios

P/E, P/S, P/B, EV/EBITDA, FCF yield, and earnings yield

P/E Ratio: 32.5x
P/S Ratio: 4.8x
P/B Ratio: 4.3x

At 32.5x P/E, the stock trades above typical market levels — the market expects above-average growth. P/S of 4.8x and P/B of 4.3x provide additional context. Use the growth and margin sections to judge whether the multiple is justified. Across the last 8 quarters, P/E has risen for 2 consecutive quarters — a weakening trend.

Assets & Liabilities

Total assets, cash, debt, book value, and leverage

Total Assets: $6.88B
Cash: $602.10M
Long-Term Debt: $1.75B
Book Value: $4.01B
D/E Ratio: 0.4
Debt/EBITDA: 6.7

With $6.88B in assets and $1.75B in long-term debt, D/E is 0.4and book value is $4.01B — a conservative capital structure with a cushion to weather downturns. Over the past year, debt/equity is down 8% — an improving trend.

Cash Flow

Operating cash flow, free cash flow, FCF margin, and earnings quality

Op. Cash Flow: $239.50M
TTM Free Cash Flow: $667.10M
FCF Margin: 18.2%
FCF / Net Income: 1.2

TTM FCF of $667.10M on $239.50M in operating cash flow. The FCF / Net Income ratio of 1.2x means free cash flow covers net income — earnings are backed by cash. Across the last 8 quarters, free cash flow has risen for 2 consecutive quarters — an improving trend.